Playlist
Turkmen Teacher in Ivanovo Achieves Near-Perfect Exam Scores with Students
21 Oct. 06:11In Ivanovo’s School No. 14, located in the Avdotyino district, mathematics and computer science teacher Umid Erkinov has become a rising star in the local education system. Originally from Turkmenistan, his students are now consistently scoring close to 100 on Russia’s Unified State Exam (EGE).
Umid moved to Russia as a young man to study at a local university, where he earned a degree in mathematics and computer science. After completing his bachelor's and then a master's program, he decided to stay and begin his teaching career.
He recalls how students initially struggled to pronounce his name, but quickly adapted within a few lessons. Though he didn’t teach in Turkmenistan, the similarities between the Russian and Turkmen education systems helped him integrate seamlessly.
Fellow teachers describe him as gifted and passionate. Students enjoy his classes, and parents appreciate his clear, engaging teaching style. Umid maintains open communication with families, offering advice and support to help each student succeed individually.
In his first year, he was entrusted with an 11th-grade class, and their final exam results were impressive — many scored 95 or 96 out of 100. Umid says he was proud of their performance and continues to see dedication in his current students.
Back home, his relatives and fellow countrymen follow his success with pride. He has become a respected educator in Russia and hopes to continue working in the Avdotyino school, possibly even building a future in Ivanovo beyond the classroom.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz